Tuesday, June 16, 2009

Radionecrosis: Fighting For RRReimbursement

So often healthcare's more about the pittance than about the patient. The medical literature and UHMS and Medicare support the use of hyperbaric oxygen to treat delayed radiation injury. Yet some major insurers have taken to categorizing HBOT as "experimental-investigational" and denying coverage. Well, the hyperbaric medicine community is fighting back. The American College of Hyperbaric Medicine's Radiation Research Registry (RRR) is tracking clinical outcomes of some 2,000 patients in 177 centers. Watch the RRR doctors plead their case below. Download the interim analysis from ACHM. And stand by for Level 1 evidence from the Baromedical Research Foundation's large HORTIS trial. Pass the ammunition.

No comments:

Post a Comment